Kemp Kernstine, M.D., Ph.D.
Dr. Kemp Kernstine is a thoracic surgeon specializing in the management of a wide spectrum of benign and malignant diseases of the chest, including lung cancer and malignant pleural mesothelioma. He practices at UT Southwestern Medical Center in Dallas, Texas, where he is Professor and Chief of the Division of Thoracic Surgery and holds the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery.[1]
Dr. Kernstine’s expertise in conditions involving the lungs, esophagus, mediastinum, and chest wall is supported by his skill in the use of robotic surgery.
Education and Career
Dr. Kernstine completed his undergraduate and medical studies at Duke University, after which he completed an internship and General Surgery residency at the University of Minnesota in Minneapolis. While there, he also completed his Ph.D. He completed further training in Heart and Lung Surgery at Brigham and Women’s Hospital of Harvard Medical School as a General Thoracic track resident. He is board-certified in Surgery and Thoracic Surgery.[1]
Professional Memberships
Dr. Kernstine is a member of and has served in leadership rules for multiple professional organizations, including:[1]
- American Medical Association
- American College of Surgeons
- American College of Chest Physicians
- American Thoracic Society
- American Association of Thoracic Surgeons
- Society of Thoracic Surgeons
- Society of Surgical Oncologists
- Western Thoracic Society
- International Society of Minimally Invasive Cardiothoracic Surgeons
Research
Dr. Kernstine is the recipient of funding from the National Cancer Institute, as well as a variety of regional and national grants to further his research interests, which include minimally invasive and robotic surgery procedures and the surgical evaluation and treatment of lung and esophageal cancer, mesothelioma, and thymic cancers. He is also interested in the treatment of benign esophageal disease and thymectomy in the treatment of myasthenia gravis.[1]
His recent publications and presentations include:[2]
Metabolic signatures of thymomas: potential biomarkers and treatment targets. James W Miller, Brandon M Faubert, Thomas P Mathews, Ralph J DeBerardinis, Kemp H Kernstine, Waters, J.>; European Journal of Cardio-Thoracic Surgery. 2024 Feb 1
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Ed… James Huang, Raymond U Osarogiagbon, Dorothy J Giroux, Katherine K Nishimura, Andrea Bille, Giuseppe Cardillo, Frank Detterbeck, Kemp Kernstine, Hong Kwan Kim, Yolande…>; Journal of Thoracic Oncology. 2023 Oct 20
Training Cardiothoracic Residents in Robotic Lobectomy Is Cost-Effective With No Change in Clinical Outcomes. James T Nawalaniec, Matthew Elson, Scott I Reznik, Michael A Wait, Matthias Peltz, Michael E Jessen, Alejandra Madrigales, Jerzy Lysikowski, Kemp H Kernstine> ;Innovations. 2022 Mar 28
